Company profile
Pharmaceutical CDMO & CRO | Quotient Sciences
Quotient Sciences is a drug development & manufacturing accelerator. As a pharmaceutical CDMO & CRO we support customers from candidate selection to commercial launch.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2018 to 31 Dec 2021
The nature of small molecule drug substance manufacturing demand is changing in response to the development of new and more targeted pharmaceutical treatments. Small molecule drug substances are becoming generally more complex in nature, more potent, and as a consequence the drug substance requirements for a candidate drug, both through the clinical devel...
